← Leaderboards
Robert K Ernst
University Of Washington
$6,785,080
Attributed
$11,109,556
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2006–24$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$11,096,138 · 11
FDA$13,418 · 1
By mechanism
R01$9,029,111 · 5
R21$1,682,463 · 4
U54$365,564 · 1
R13$32,418 · 2
Top collaborators
- David Robinson Goodlett13 shared
- Yohei Doi5 shared
- Alan S Cross2 shared
- Alison J Scott2 shared
- Stefanie N. Vogel2 shared
Most similar at University Of Washington
Same institution · by research overlap
- Margaret Rosenfeld$6,120,159
- Kathleen Jessica Ramos$3,387,316
- Donald Leslie Chi$10,851,003
- Samuel I. Miller$34,128,042
- Samuel M Moskowitz$3,526,859
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionLipid APathogenStructureAntibioticsBacteriaMembraneLipidsFundingLaboratoriesBaseModificationMorbidity - Disease RateLipopolysaccharidesDesignIn VitroMortalityClinically RelevantMass Spectrum AnalysisGram-Negative BacteriaGrowthProtocols DocumentationCessation Of LifeMediating
Grant awards (34)
Colistin resistance in extensively drug-resistant Gram-negative pathogens$468,483
R01 · FY2024 · AI
MS Diagnostic Bacterial Identification Library$463,500
R01 · FY2024 · AI · contact PI
Microbial adaptation of Pseudomonas lipid A structure in CF airway disease progress$193,125
R21 · FY2024 · AI
Colistin resistance in extensively drug-resistant Gram-negative pathogens$468,483
R01 · FY2023 · AI
MS Diagnostic Bacterial Identification Library$463,500
R01 · FY2023 · AI · contact PI
Microbial adaptation of Pseudomonas lipid A structure in CF airway disease progress$231,750
R21 · FY2023 · AI
Colistin resistance in extensively drug-resistant Gram-negative pathogens$467,659
R01 · FY2022 · AI
MS Diagnostic Bacterial Identification Library$463,500
R01 · FY2022 · AI · contact PI
Mid-Atlantic Microbial Pathogenesis Meeting 2022$13,418
R13 · FY2022 · FD · contact PI
Colistin resistance in extensively drug-resistant Gram-negative pathogens$465,187
R01 · FY2021 · AI
MS Diagnostic Bacterial Identification Library$463,500
R01 · FY2021 · AI · contact PI
Colistin resistance in extensively drug-resistant Gram-negative pathogens$493,437
R01 · FY2020 · AI
MS Diagnostic Bacterial Identification Library$463,500
R01 · FY2020 · AI · contact PI
Bi Annual Mid-Atlantic Microbial Pathogenesis Meeting (MAMPM)$19,000
R13 · FY2020 · AI · contact PI
Protection Against Gram-Negative Sepsis Conferred by Lipid A-Based Structural Variants$386,250
R01 · FY2019 · AI · contact PI
Novel Vaccine For Multidrug-Resistant Gram-negative Bacterial Infections$193,125
R21 · FY2019 · AI
Protection Against Gram-Negative Sepsis Conferred by Lipid A-Based Structural Variants$386,250
R01 · FY2018 · AI · contact PI
Novel Vaccine For Multidrug-Resistant Gram-negative Bacterial Infections$231,750
R21 · FY2018 · AI
Protection Against Gram-Negative Sepsis Conferred by Lipid A-Based Structural Variants$386,250
R01 · FY2017 · AI · contact PI
MS diagnostic bacterial identification library$291,650
R01 · FY2017 · GM
Protection Against Gram-Negative Sepsis Conferred by Lipid A-Based Structural Variants$385,209
R01 · FY2016 · AI · contact PI
MS diagnostic bacterial identification library$291,650
R01 · FY2016 · GM
MS diagnostic bacterial identification library$291,650
R01 · FY2015 · GM
MS diagnostic bacterial identification library$277,419
R01 · FY2014 · GM
Development of a Rationally Attenuated Live Vaccine for Francisella tularensis$230,250
R21 · FY2014 · AI · contact PI
Immunotherapeutic Potential of Modified Lipooligosaccharides and Lipid A's$230,225
R21 · FY2014 · AI · contact PI
Development of a Rationally Attenuated Live Vaccine for Francisella tularensis$191,875
R21 · FY2013 · AI · contact PI
Immunotherapeutic Potential of Modified Lipooligosaccharides and Lipid A's$180,363
R21 · FY2013 · AI · contact PI
Pseudomonas aeruginosa lipid A$318,272
R01 · FY2010 · AI · contact PI
Pseudomonas aeruginosa lipid A$321,486
R01 · FY2009 · AI · contact PI
Bacterial Lipopolysaccharide Structure$365,564
U54 · FY2008 · AI · contact PI
Pseudomonas aeruginosa lipid A$321,486
R01 · FY2008 · AI · contact PI
Pseudomonas aeruginosa lipid A$340,821
R01 · FY2007 · AI · contact PI
Pseudomonas aeruginosa lipid A$349,969
R01 · FY2006 · AI · contact PI